Tadas Trunca, MSc, MBA

Experience

• 

  Thermo Fisher Scientific

  Oct 2014 - Dec 2022

  - Full focus on mRNA & RNA raw materials portfolio oversight:1) DNA template enzymes and nucleotides2) mRNA synthesis enzymes, nucleotides (non modified and modified), buffers3) Capping enzymes and chemical cap analogs4) Phosphoramidites for RNA/DNA therapeutics - Acted as "CEO” on strategic product portfolio management.- Demonstrated empowerment in leading and influencing teams, leading multi-functional teams and managing executive communication.- Successfully executed on Product Portfolio Roadmaps in close collaboration with R&D: launched strategic new enzymes and nucleotides product innovation phase-gate new product implementation projects:Highlight - mRNA IVT Enzyme project started in 2017 (Pre-COVID) and commercialized in 2021 (accelerated during COVID) that generated multimillion U.S. dollar incremental revenue, successfully enabled mRNA drug launches and set foundation for Nucleic Acid Therapeutics Business Unit establishment.- Leveraged strong hard (business, financial, technology) and soft (communication, influence) skills in communicating with customers to build relationships in order to gain access to raw material supply (pitching product and corporate value proposition, negotiating on proposals, bringing non-bias assurance to sales conversations), collect market intelligence (technology trends, customer wants, product requirements, competitor positioning) in order to define portfolio strategies (innovation, pricing) and grow top line (revenue) and bottom line (gross margin) targets.- Led and raised a global (Europe, USA) Product Management organization with overall 12 Product Managers. Show less - Responsibilities expanded to oversee 3 product portfolios: mRNA raw materials, molecular diagnostics and gene synthesis portfolios (genes, gene-to-protein products).- Focus on top line revenue management, global people management (Europe & US), product strategies and roadmaps, pricing strategies and guidelines, competitive analysis, customer intimacy to identify value, detailed product definitions, NPI (New Product Implementation) leadership.- Led a global Team of total 50 employees: 20 Products Managers (Lithuania, Germany, USA) and 30 Project Management/Customer Care associates (Germany, USA). Show less

  • Sr. Manager, Product Management, Nucleic Acid Therapeutics

    Nov 2020 - Dec 2022

  • Sr. Manager, Product Management, RNA therapeutics, Molecular Diagnostics & Gene Synthesis

    Dec 2019 - Nov 2020

  • Manager, Product Management, mRNA IVT & Molecular Diagnostics

    Apr 2018 - Dec 2019

  • Value Stream Manager, Operations

    Mar 2016 - Apr 2018

  • Client Services Project Manager, Operations, mRNA & Molecular Diagnostics Raw Materials

    Oct 2014 - Mar 2016
• 

  Lavango

  Mar 2022 - now

  Member Board Of Directors

  Oversee holding company and group companies with focus on strategic planning, commercial strategy and execution as well as sustainable business growth.

• 

  Cytiva

  Jan 2023 - now

  Leading global Nucleic Acids (mRNA, Oligonucleotides) & Nanomedicine (Lipid Nanoparticles (LNP)) Product Management organization. Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics.

  • Sr. Director, Product Management, Nucleic Acids & Nanomedicine

    Jul 2024 - now

  • Product Portfolio Leader, Nucleic Acid Therapeutics

    Jan 2023 - Jul 2024